Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats

Zikra Zulfiqar, Fawad Ali Shah, Shagufta Shafique, Abdullah Alattar, Tahir Ali, Arooj Mohsin Alvi, Sajid Rashid, Shupeng Li

Open source

DOI
10.2147/jir.s284471
Published
2020-12
Container
Journal of Inflammation Research
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/jir.s284471,
  title = {Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats},
  author = {Zikra Zulfiqar and Fawad Ali Shah and Shagufta Shafique and Abdullah Alattar and Tahir Ali and Arooj Mohsin Alvi and Sajid Rashid and Shupeng Li},
  year = {2020},
  journal = {Journal of Inflammation Research},
  doi = {10.2147/jir.s284471},
  url = {https://doi.org/10.2147/jir.s284471}
}

RIS

TY  - JOUR
TI  - Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats
AU  - Zikra Zulfiqar
AU  - Fawad Ali Shah
AU  - Shagufta Shafique
AU  - Abdullah Alattar
AU  - Tahir Ali
AU  - Arooj Mohsin Alvi
AU  - Sajid Rashid
AU  - Shupeng Li
PY  - 2020
JO  - Journal of Inflammation Research
DO  - 10.2147/jir.s284471
UR  - https://doi.org/10.2147/jir.s284471
ER  - 

APA

Zulfiqar, Z., Shah, F. A., Shafique, S., Alattar, A., Ali, T., Alvi, A. M., Rashid, S., & Li, S. (2020). Repurposing FDA Approved Drugs as JNK3 Inhibitor for Prevention of Neuroinflammation Induced by MCAO in Rats. Journal of Inflammation Research. https://doi.org/10.2147/jir.s284471

Source records